Cite

HARVARD Citation

    Zhou, Z. et al. (2022). Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS‐CoV‐2 Omicron BA.1 variant. MedComm. 3 (2), p. n/a. [Online]. 
  
Back to record